Bigfoot Unity Diabetes Management System

Hand holding Bigfoot rapid-acting smart insulin pen
FDA greenlights Bigfoot Biomedical's insulin recommending diabetes management system
By Mallory Hackett | 12:58 pm | May 10, 2021
The system was cleared for use among individuals 12 years old and up with Type 1 or Type 2 diabetes on multiple-dose injection therapy.